Manipulating mitochondrial electron flow enhances tumor immunogenicity
Science · 22.09.2023 · 381 (6664) · 1316-1323
DOI: 10.1126/science.abq1053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 22.09.2023. Verfasst von Kailash Chandra Mangalhara und 20 weiteren Autor:innen. Beteiligte Einrichtung: Salk Institute for Biological Studies, La Jolla, CA 92037, USA. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Electron Transport Complex I, Electron Transport Complex II, Mitochondria. Die Arbeit wurde bisher 137-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Although tumor growth requires the mitochondrial electron transport chain (ETC), the relative contribution of complex I (CI) and complex II (CII), the gatekeepers for initiating electron flow, remains unclear. In this work, we report that the loss of CII, but not that of CI, reduces melanoma tumor growth by increasing antigen presentation and T cell–mediated killing. This is driven by succinate-mediated transcriptional and epigenetic activation of major histocompatibility complex–antigen processing and presentation (MHC-APP) genes independent of interferon signaling. Furthermore, knockout of methylation-controlled J protein (MCJ), to promote electron entry preferentially through CI, provides proof of concept of ETC rewiring to achieve antitumor responses without side effects associated with an overall reduction in mitochondrial respiration in noncancer cells. Our results may hold therapeutic potential for tumors that have reduced MHC-APP expression, a common mechanism of cancer immunoevasion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
- Department of Pathology, Yale University School of Medicine, New Haven, CT 06520, USA.
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
- Whitehead Institute Metabolomics Core Facility, Cambridge, MA 02139, USA.
ORCID-Profile: Kailash Chandra Mangalhara, Melissa A Johnson, Mannix J Burns, Pau B Esparza Moltó, Keene L Abbott, Gaurav Mendiratta, Dan Chen, Tenzin Kunchok, Matthew G Vander Heiden, Marcus Bosenberg, Diana C Hargreaves, Susan M Kaech, Gerald S Shadel
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NIAID NIH HHS
- NIA NIH HHS
- NIH HHS
Zitieren
APA
Mangalhara, K. C., Varanasi, S. K., Johnson, M. A., Burns, M. J., Rojas, G. R., Esparza Moltó, P. B., Sainz, A. G., Tadepalle, N., Abbott, K. L., Mendiratta, G., Chen, D., Farsakoglu, Y., Kunchok, T., Hoffmann, F. A., Parisi, B., Rincon, M., Vander Heiden, M. G., Bosenberg, M., Hargreaves, D. C., …, & Shadel, G. S. (2023). Manipulating mitochondrial electron flow enhances tumor immunogenicity. Science, 381(6664), 1316-1323. https://doi.org/10.1126/science.abq1053
Vancouver
Mangalhara KC, Varanasi SK, Johnson MA, Burns MJ, Rojas GR, Esparza Moltó PB, et al. Manipulating mitochondrial electron flow enhances tumor immunogenicity. Science. 2023;381(6664):1316-1323. doi:10.1126/science.abq1053
BibTeX
@article{Mangalhara2023,
author = {Mangalhara, Kailash Chandra and Varanasi, Siva Karthik and Johnson, Melissa A and Burns, Mannix J and Rojas, Gladys R and Esparza Moltó, Pau B and Sainz, Alva G and Tadepalle, Nimesha and Abbott, Keene L and Mendiratta, Gaurav and Chen, Dan and Farsakoglu, Yagmur and Kunchok, Tenzin and Hoffmann, Filipe Araujo and Parisi, Bianca and Rincon, Mercedes and Vander Heiden, Matthew G and Bosenberg, Marcus and Hargreaves, Diana C and Kaech, Susan M and Shadel, Gerald S},
title = {Manipulating mitochondrial electron flow enhances tumor immunogenicity},
journal = {Science},
year = {2023},
volume = {381},
number = {6664},
pages = {1316--1323},
doi = {10.1126/science.abq1053}
}
EUVIMED